Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Phico Therapeutics
Phico Therapeutics
Activities:
Research & Development
Infection Control
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
The (r)evolution of biocatalysis in API synthesis
Explore Farmhispania Group’s enzyme toolbox to develop cost-effective, green-by-design synthetic routes for the cGMP production of your small-molecule NCEs
From batch to continuous chemistry to continuous processing
The main challenge in many flow reactors lies in achieving a smooth and continuous flow within microchannels. Dec Group focuses on effectively transporting solid materials and...
PCI Pharma Services commences installation of sterile fill-finish and lyophilisation line
The Bedford, NH site will advance PCI's manufacturing capabilities with twin lyophilisers and a large-scale isolator filling line, making this the third sterile fill-finish...
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Phico Therapeutics appoints Financial Director and two non-executives
Pharmaceutical
Phico Therapeutics awarded Innovate UK funding
The funding will support development of a <i>Pseudomonas aeruginosa</i> targeted therapeutic, to tackle the genetic cause of antibiotic resistance
Research & Development
Phico Therapeutics receives £2.25m grant to advance its SASPject PT4 towards clinical trials
The antibiotic is aimed at Escherichia coli and Klebsiella pneumoniae
Research & Development
Phico raises further funds to fight E.coli
To develop SASPject antibiotic technology
Research & Development
Phico Therapeutics raises £1.8m to advance new class of antibiotics
Technology could form the basis of a new class of antibiotics
Subscribe now